Past Meetup

#innovateinRVA w/ TAILORx

This Meetup is past

3 people went

Location image of event venue


Data from the Trial Assigning Individualized Options for Treatment (TAILORx) show that chemotherapy does not increase disease-free survival rates for women with early stage breast cancer and an intermediate risk of recurrence determined by the Oncotype DX Recurrence Score test. The study was designed to more precisely determine the effect of chemotherapy, if any, for women with hormone receptor (HR)-positive, HER2-negative, axillary lymph node-negative breast cancer.

Hear from the study co-author and physician-researcher Charles Geyer, M.D., associate director for clinical research at VCU Massey Cancer Center and learn more about this groundbreaking study.

Register Here: